We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Study of Everolimus and Low-dose Cyclophosphamide in Patients With Metastatic Renal Cell Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01462214
Recruitment Status : Completed
First Posted : October 31, 2011
Last Update Posted : May 10, 2017
Dutch Cancer Society
Information provided by (Responsible Party):
Hans J. van der Vliet, MD, PhD, VU University Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : January 2017
  Study Completion Date : January 2017